Pfizer

Moderna’s Spikevax has higher risk of heart inflammation than Pfizer’s Comirnaty: Study
Moderna’s Spikevax has higher risk of heart inflammation than Pfizer’s Comirnaty: Study
Medical Marketing and Media
Pfizer
Moderna Therapeutics
vaccines
COVID-19
myocarditis
Flag link:
Pfizer tops pharma reputation rankings from autoimmune patients
Pfizer tops pharma reputation rankings from autoimmune patients
Medical Marketing and Media
Pfizer
autoimmune disease
reputation
Flag link:
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Pfizer’s Elranatamab Granted FDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma
Drugs.com
Pfizer
elranatamab
FDA
breakthrough therapy
relapsed or refractory multiple myeloma
Flag link:
Pfizer, BioNTech start COVID-flu combination vaccine study
Pfizer, BioNTech start COVID-flu combination vaccine study
Reuters
Pfizer
BioNTech
vaccines
Flu
COVID-19
clinical trials
Flag link:
With FDA decision penciled in for May, GSK powers ahead in RSV race with Pfizer
With FDA decision penciled in for May, GSK powers ahead in RSV race with Pfizer
Fierce Biotech
GSK
Pfizer
RSV
vaccines
FDA
Flag link:
FDA chief stands by Paxlovid nod amid discussion on 'rebound' cases
FDA chief stands by Paxlovid nod amid discussion on 'rebound' cases
Fierce Pharma
Pfizer
Paxlovid
antivirals
COVID-19
FDA
Robert Califf
Flag link:
After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year
After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year
CNN
Pfizer
vaccines
RSV
maternal vaccines
clinical trials
FDA
Flag link:
Pfizer discards eczema, NASH and breast cancer programs in early-phase clean-out
Pfizer discards eczema, NASH and breast cancer programs in early-phase clean-out
Fierce Biotech
Pfizer
R&D
NASH
breast cancer
eczema
Flag link:
Eli Lilly revenue inches up 2%, Pfizer raises full year outlook
Eli Lilly revenue inches up 2%, Pfizer raises full year outlook
Medical Marketing and Media
Eli Lilly
Pfizer
earnings
Flag link:
Pfizer under Italian finance probe over alleged $1.2B profits offshoring
Pfizer under Italian finance probe over alleged $1.2B profits offshoring
Fierce Pharma
Pfizer
Italy
taxes
offshoring
Flag link:
After going head-to-head with Prevnar 20, Vaxcyte's 24-valent pneumococcal shot will seek a pivotal win
After going head-to-head with Prevnar 20, Vaxcyte's 24-valent pneumococcal shot will seek a pivotal win
Endpoints
Vaxcyte
vaccines
VAX-24
pneumococcal disease
Pfizer
Prevnar 20
clinical trials
Flag link:
Pfizer blueprints €1B site in Ireland as industry's local investment spree rolls on: report
Pfizer blueprints €1B site in Ireland as industry's local investment spree rolls on: report
Fierce Pharma
Pfizer
Ireland
drug manufacturing
Flag link:
As government funding dries up, Pfizer expects to charge private payers $110+ for Covid-19 vaccine
As government funding dries up, Pfizer expects to charge private payers $110+ for Covid-19 vaccine
Endpoints
Pfizer
BioNTech
payers
vaccines
COVID-19
Flag link:
Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing
Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing
BioSpace
Erasca
Pfizer
ERAS-007
Ibrance
colorectal cancer
Flag link:
Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report
Pfizer CEO Bourla says company ready to execute in a 'pivotal' 2023: report
Fierce Pharma
Pfizer
Pharma CEOs
Albert Bourla
drug launches
COVID-19
vaccines
Flag link:
AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial
AM-Pharma, once a Pfizer takeover target, flunks phase 3 kidney injury trial
Fierce Biotech
AM-Pharma
clinical trials
kidney injury
Pfizer
Flag link:
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
Pfizer, Merck and J&J Back UK Startup Mining the Dark Genome for Autoimmune Therapies
BioSpace
Nucleome Therapeutics
funding
precision medicine
autoimmune diseases
Pfizer
JNJ
Merck KGaA
autoimmune disease
Flag link:
Pfizer takes Vyndaqel copay fight to Supreme Court, decrying 'staggeringly overbroad' anti-kickback rule
Pfizer takes Vyndaqel copay fight to Supreme Court, decrying 'staggeringly overbroad' anti-kickback rule
Fierce Pharma
Pfizer
Supreme Court
kickbakcs
tafamidis
copays
Vyndaqel
Flag link:
FDA Review: Phanes, Pfizer, GSK and More
FDA Review: Phanes, Pfizer, GSK and More
BioSpace
FDA
Phanes
Pfizer
GSK
Regeneron
Eagle Pharmaceuticals
Galactin Therapeutics
BridgeBio
Gilead Sciences
Covis Pharma
scPharmaceuticals
XACT Robotics
BioMind Labs
Flag link:
Few safe havens surface in another down quarter for biopharma
Few safe havens surface in another down quarter for biopharma
EP Vantage
biopharma stocks
COVID-19
Eli Lilly
Bristol Myers Squibb
Merck
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Neurocrine
Sarepta Therapeutics
Orion
Pfizer
GSK
Roche
Moderna Therapeutics
BeiGene
BioNTech
Novavax
CureVac
Flag link:

Pages